Atai Life Sciences N.V. (ATAI)
1.33
-0.09 (-6.34%)
At close: Jan 14, 2025, 3:59 PM
1.31
-1.48%
Pre-market Jan 15, 2025, 04:09 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 314.00K | 233.00K | 20.38M | n/a | n/a |
| Cost of Revenue | n/a | 168.00K | 47.00K | 24.00K | 6.00K |
| Gross Profit | 314.00K | 65.00K | 20.33M | -24.00K | -6.00K |
| Operating Income | -125.47M | -144.79M | -135.81M | -104.16M | 1.57M |
| Interest Income | 1.85M | 548.00K | 205.00K | 71.00K | 23.00K |
| Pretax Income | -39.29M | -135.18M | -136.60M | -101.81M | -17.47M |
| Net Income | -40.22M | -141.41M | -132.61M | -102.12M | -17.48M |
| Selling & General & Admin | 63.58M | 70.35M | 92.75M | 80.73M | 5.09M |
| Research & Development | 62.20M | 74.31M | 47.96M | 11.41M | 3.08M |
| Other Expenses | n/a | 9.61M | -796.00K | -16.09M | 425.00K |
| Operating Expenses | 125.78M | 144.66M | 140.70M | 92.14M | 8.17M |
| Interest Expense | 2.66M | 1.92M | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 125.78M | 144.66M | 140.70M | 92.14M | 8.17M |
| Income Tax | 1.02M | 6.23M | -3.99M | 305.00K | 2.00K |
| Shares Outstanding (Basic) | 158.83M | 155.72M | 160.68M | 5.81M | 5.42M |
| Shares Outstanding (Diluted) | 158.83M | 155.72M | 160.68M | 5.81M | 5.42M |
| EPS (Basic) | -0.25 | -0.91 | -0.83 | -17.57 | -3.23 |
| EPS (Diluted) | -0.25 | -0.91 | -0.83 | -17.57 | -3.23 |
| EBITDA | -36.31M | -135.01M | -120.28M | -92.12M | -17.47M |
| Depreciation & Amortization | 319.00K | 168.00K | 47.00K | 24.00K | 6.00K |